Subcutaneous Rapid‐Acting Insulin Analogs for Diabetic Ketoacidosis

alexandrossfakianakis shared this article with you from Inoreader Subcutaneous Rapid‐Acting Insulin Analogs for Diabetic Ketoacidosis Via Wiley: Academic Emergency Medicine: Table of Contents Abstract Diabetic ketoacidosis (DKA), characterized by hyperglycemia, metabolic acidosis, and ketosis, is a serious complication of diabetes mellitus. Treatment focuses on fluid restoration, correction of hyperglycemia, and inhibition of ketogenesis. Insulin is considered a fundamental component of DKA treatment as it promotes the peripheral tissues' utilization of glucose in peripheral tissues by reducing hepatic gluconeogenesis and suppressing ketogenesis.1 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.